Skip to content
easybpt
Browse topics

Pharmacology

Opioid toxicity and opioid-induced hyperalgesia in palliative care

Why opioid toxicity develops in palliative patients (renal accumulation of active metabolites, dose escalation, interactions), how to tell opioid-induced neurotoxicity and hyperalgesia from tolerance and disease progression, and the pharmacology behind dose reduction, rotation, naloxone titration and NMDA antagonists.

Tier 2Medical sciences concept

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions8 flashcards

At a glance

  • Opioid toxicity in palliative care is usually iatrogenic and gradual: renal function falls, a dose is escalated, an interacting drug is added, or pain is relieved by radiotherapy or a nerve block so the same dose is now too much.
  • Two pictures overlap. Classical mu toxicity (sedation, miosis, slow breathing) and opioid-induced neurotoxicity (OIN): myoclonus, delirium, hallucinations, allodynia and hyperalgesia.
  • Opioid-induced hyperalgesia (OIH) is increased pain sensitivity caused by the opioid itself. Pain becomes diffuse and worsens as the dose goes up.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions8 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Personal emails, About story and Australian-style copy

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.